In a critical warning, the World Health Organization (WHO) has raised the alarm about counterfeit semaglutide injections—specifically, falsified batches of the popular weight-loss and type 2 diabetes drug Ozempic. Let’s dive into the details of this urgent health advisory.
1. Ozempic Under Scrutiny
Ozempic, a blockbuster drug used to treat obesity and type 2 diabetes, has faced a concerning development. The WHO identified three falsified batches of this injectable medication in Brazil, the UK, and the US during 2023. Healthcare professionals, regulatory authorities, and the public are urged to be vigilant regarding these suspicious medicines.
2. Navigating the Counterfeit Market
High demand for Ozempic, also marketed as Wegovy and Rybelsus, has led to shortages and a thriving counterfeit market. These drugs mimic a gut hormone, enhancing insulin production and slowing down food digestion. Novo Nordisk, the Danish pharmaceutical company, markets these medications.
3. Health Risks and Ineffectiveness
The WHO emphasizes that purchasing Ozempic from unverified sources poses serious risks. Notably, Ozempic and Wegovy are not currently recommended by the global health agency for diabetes treatment due to their high cost. Using fake Ozempic could lead to ineffective treatment or jeopardize patients’ well-being.
4. European Warnings and Hospitalizations
The European Medicines Agency (EMA) previously alerted about falsified pre-filled Ozempic pens in the EU and UK. Some patients were hospitalized after unknowingly using counterfeit versions, experiencing hypoglycemia and seizures. The stakes are high, urging caution and vigilance.
5. Eli Lilly’s Battle Against Counterfeits
Pharmaceutical giant Eli Lilly is also combatting counterfeit weight-loss drugs. The company takes legal action against centers selling unapproved or compounded versions of tirzepatide—the active ingredient in their drugs Mounjaro and Zepbound. Safety, sterility, and efficacy are at stake, as counterfeit products threaten patient health and undermine trust in legitimate medications.
SOURCE: Ref Image from The Telegraph
Whether writing about complex technical topics or breaking news stories, my writing is always clear, concise, and engaging. My dedication to my craft and passion for storytelling have earned me a reputation as a highly respected article writer.